Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Design and Optimization of Solid Dispersed Osmotic Pump Tablets of Aceclofenac, A Better Approach to Treat Arthritis

  • Edavalath, Sudeesh (Pharmaceutics Research Laboratory, Nehru College of Pharmacy) ;
  • Rao, B. Prakash (Department of Pharmaceutics, Karnataka College of Pharmacy)
  • Received : 2011.04.29
  • Accepted : 2011.07.05
  • Published : 2011.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this work was to prepare porous osmotic pump tablets for controlled delivery of Aceclofenac. Aceclofenac solid dispersion was prepared to improve the solubility by using the drug - carrier (Mannitol) ratio of 1:1. The osmotic pump tablets were prepared using the solid dispersed product of Aceclofenac. The formulation contains potassium chloride as osmotic agent, cellulose acetate as semipermeable membrane, poly ethylene glycol (PEG 4000) as pore former and sodium lauryl sulphate (SLS) as solubility enhancer. The formulations were designed by the general factors such as osmotic agent and pore former. All formulations were evaluated for various physical parameters and, the in vitro release studies were conducted as per USP. The drug release kinetic studies such as zero order, first order, and Higuchi and Korsmeyer peppas were determined and compared. All the formulations gave more controlled release compared to the marketed tablet studied. Numerical optimization techniques were applied to found out the best formulation by considering the parameter of in vitro drug release kinetics and dissolution profile standards. It was concluded that the porous osmotic pump tablets (F7) composed of Aceclofenac solid dispersion/Potassium chloride/Lactose/Sodium lauryl sulphate/Magnesium Stearate (400/40/95/10/5, mg/tab) and coating composition with Cellulose acetate/ PEG 4000 (60/40 %w/w) is the most satisfactory formulation. The porous osmotic pump tablets provide prolonged, controlled, and gastrointestinal environment-independent drug release.

Keywords

References

  1. Banker, G.S., 2007. Rhodes CT. Modern pharmaceutics. 4th ed. New York: Marcel Dekker 501-513, 727-752.
  2. Charles, R.C., Robert, E.S., 2005. Modern pharmacology and clinical applications. 6th ed. 314.
  3. Chauhan, C.S., Choudhury, P.K., 2006. Controlled porosity osmotic pump for the delivery of flurbiprofen. Current Drug Delivery 3, 193-198. https://doi.org/10.2174/156720106776359203
  4. Chien, Y.W., 2005. Novel drug delivery systems. 2nd ed. New York: Marcel Dekker. 50, 139-196.
  5. Donald, L.W., 2000. Hand book of pharmaceutical controlled release technology. New York: Marcel Dekker. 183-188, 225- 54, 431-436.
  6. Gohel, M.C., Parikh, R.K., Shah, NY., Osmotic drug delivery: An update. [Online]. [2009 Feb 10]; 7(2). Available from: URL:http://www.pharmainfo.net/reviews/osmotic-drug-delivery-update.
  7. Indian Pharmacopoeia. Ghaziabad: The Indian Pharmacopoeia Commission, 2007. 731-734, 477-480.
  8. James, S., 2007. Encyclopedia of pharmaceutical technology. 3rd ed. New York: Informa healthcare, 2452-2466.
  9. Kanagale, P., Lohray, B.B., Misra, A., Davadra, P., Kini, R., 2007. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS Pharm Sci Tech, 8(3), E1-7. https://doi.org/10.1208/pt0803051
  10. Makhija, S.N., Vavia, P.R., 2003. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I. Cellulose acetate as a semi permeable membrane. J. Control Release. 89, 5-18. https://doi.org/10.1016/S0168-3659(02)00482-0
  11. Prakash, R.B., Geetha, M., Purushothama, N., Utpal, S., 2009. Optimization and development of swellable controlled porosity osmotic pump tablet for theophylline. Trop J Pharm Research; 8(3), 247-255.
  12. Rani, M., Surana, R., Sankar, C., Mishra, B., 2003. Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium. Acta Pharm, 53, 263-273.
  13. Robinson, J.R., Vincent, H.L.T., 2005. Controlled drug delivery fundamentals and applications. 2nd ed. New York: Marcel Dekker; 29, 373-403.
  14. Sharma, S. Osmotic controlled drug delivery system. [Online]. [2008 Oct 20]; [1]. Available from: URL:http://www.pharmainfo. net/reviews/osmotic-controlled-drug-delivery-system.
  15. Sudeesh, E., Shivanand, K., Kalyani, P., Prakash, R.B., Goli, D., 2011. Formulation development and optimization of controlled porosity osmotic pump tablets of diclofenac sodium. Int J Pharm Pharm Sci, 3(1), 80-87.
  16. Thripathi, K.D., 1999. Essentials of medical pharmacology. 4th ed. New Delhi: Jaypee brothers medical publishers(P)Ltd, 462.